Débora Claramunt Taberner-rekin lankidetzan egindako argitalpenak (8)

2019

  1. Correction to: X-linked hypophosphatemia and growth (Reviews in Endocrine and Metabolic Disorders, (2017), 18, 1, (107-115), 10.1007/s11154-017-9408-1)

    Reviews in Endocrine and Metabolic Disorders

  2. MAPK inhibition and growth hormone: a promising therapy in XLH

    FASEB Journal, Vol. 33, Núm. 7, pp. 8349-8362

2018

  1. Marked alterations in the structure, dynamics and maturation of growth plate likely explain growth retardation and bone deformities of young Hyp mice

    Bone, Vol. 116, pp. 187-195

2017

  1. Effects of growth hormone treatment on growth plate, bone, and mineral metabolism of young rats with uremia induced by adenine

    Pediatric Research, Vol. 82, Núm. 1, pp. 148-154

  2. X-linked hypophosphatemia and growth

    Reviews in Endocrine and Metabolic Disorders, Vol. 18, Núm. 1, pp. 107-115

2015

  1. Animal models of pediatric chronic kidney disease. Is adenine intake an appropriate model?

    Nefrologia

  2. Chronic kidney disease induced by adenine: A suitable model of growth retardation in uremia

    American Journal of Physiology - Renal Physiology, Vol. 309, Núm. 1, pp. F57-F62

  3. Clinical and laboratory approaches in the diagnosis of renal tubular acidosis

    Pediatric Nephrology, Vol. 30, Núm. 12, pp. 2099-2107